Basic Information
Levo Therapeutics is a biotechnology company dedicated to advancing the treatment of Prader-Willi syndrome and related diseases by leveraging genetic knowledge. The company's primary candidate product is LV-101 (intranasal carbetocin).
Levo Therapeutics Inc.
Illinois,United States of America
less than 15 people
January 01, 2016
contactus@levotx.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios